Clinical Trials
7 trialsNCT02253316 2025-11-10
Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
Washington University School of Medicine
Phase 2 Active not recruiting
NCT06855628 2025-10-28
Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)
Stanford University
Phase 2 Suspended
NCT00597909 2024-12-17
Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Amgen
Phase 2 Terminated
NCT04782856 2024-06-14
Energy Metabolism in Thyroidectomized Patients
Virginia Commonwealth University
Phase 2 Completed
NCT04863248 2023-04-14
PRESERVE 4
G1 Therapeutics, Inc.
Phase 2 Terminated
NCT00753740 2020-06-12
Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.
Lumos Pharma
Phase 2 Withdrawn
NCT02012608 2019-05-29
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
University of Arkansas
Phase 2 Terminated